Pharmaceutical composition and functional health food for prevention or treatment of diseases relating to bone mass loss including HS1792 or its pharmaceutically acceptable salts

摘要

The present invention relates to a dietary supplement in the pharmaceutical compositions and osteoporosis inhibitory ability for the prevention and treatment of bone mass decrease-related diseases, including acceptable salts HS1792, or a pharmaceutically thereof, and more particularly, HS1792 of the invention is a bone resorption inhibition and relates to a functional food which reduces the expression of osteoclast differentiation associated gene to generate an effective bar inhibition and treatment of osteoporosis, bone mass or preventing osteoporosis inhibitory ability of pharmaceutical compositions and for the treatment of reduced related diseases comprising the same. ;